Abstract
Superantigens use an elaborate and unique mechanism of T lymphocyte stimulation. Prototype superantigen are the pyrogenic exotoxins produced by Staphylococcus aureus and Streptococcus pyogenes. Many candidate proteins of bacterial, viral and protozoal origin have recently been reported to be superantigens. In most cases the evidence that these proteins are in fact superantigens is highly indirect. In this review the evidence that grampositive cocci produce superantigens other than the pyrogenic exotoxins is critically discussed. Evidence in described demonstrating that the epidermolytic toxins of Staphylococcus aureus and the pyrogenic exotoxin B and M-proteins of Streptococcus pyrogenes are not superantigens. Criteria are described for acceptance of a candidate as a superantigen.
Similar content being viewed by others
References
Fleischer B, Schrezenmeier H (1988) T cell Stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for MHC class II molecules on accessory or target cells. J Exp Med 167: 1697–1708
Janeway CA Jr (1991) Selective elements for the V β region of the T cell receptor: Mls and the bacterial toxic mitogens. Adv Immunol 50: 1–53
White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P (1989) The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56: 27–35
Held W, Acha-Orbea H, MacDonald HR, Waanders GA (1994) Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol Today 15: 184–190
Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J, Kappler JW (1993) The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol Rev 131: 79–92
Matthes M, Schrezenmeier H, Homfeld J, Fleischer S, Malissen B, Kirchner H, Fleischer B (1988) Clonal analysis of human T cell activation by the mycoplasma arthritidis mitogen. Eur J Immunol 18: 1733–1737
Cole BC, Atkin CL (1991) The Mycoplasma arthritidis T cell mitogen MAM: a model superantigen. Immunol Today 12: 271–276
McClane BA (1994) Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes. Toxicology 87: 43–67
Lee PK, Schlievert PM (1991) Molecular genetics of pyrogenic exotoxin “superantigen” of group A streptococci and Staphylococcus aureus. Curr Top Microbiol Immunol 174: 1–20
Betley MJ, Borst DW, Regassa LB (1992) Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol 55: 1–35
Marrack P, Kappler JW (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705–711
Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser JM, Rich RR (1994) Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun 62: 1867–1874
Fleischer B (1995) Bacterial superantigens. Rev Med Microbiol 6: (in press)
Bergdoll MS (1983) Enterotoxins. In: Easmon SCF, Adlams C (eds) Staphylococci and staphylococcal infections. Academic Press, New York, pp 559–598
Musser JM, Schlievert PM, Chow AW, Ewan P, Kreiswirth BN, Rosdahl VT, Naidu AS, Witte W, Selander RK (1990) A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci USA 87: 225–229
Marr JC, Lyon JD, Roberson JR, Lupher M, Davis WC, Bohach GA (1993) Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications. Infect Immun 61: 4254–4262
Fleischer B, Gerardy-Schahn R, Metzroth B, Carrel S, Gerlach D, Köhler W (1991) A conserved mechanism of T cell stimulation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol 146: 11–17
Lee PK, Kreiswirth BN, Deringer JR, Projan SJ, Eisner W, Smith BL, Carlson E, Novick RP, Schlievert PM (1992) Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine-and bovine-associated Staphylococcus aureus. J Infect Dis 165: 1056–1063
Fleming S, Iandolo J, Chapes S (1991) Murine macrophage activation by staphylococcal exotoxins. Infect Immun 59: 4049–4055
Chapes S, Hoynowski SM, Woods KM, Armstrong JW, Beharka AA, Iandolo JJ (1994) Staphylococcus-mediated T-cell activation and spontaneous natural killer cell activity in the absence of major histocompatibility complex class II molecules. Infect Immun 61: 4013–4016
Leonard BA, Lee PK, Jenkins MK, Schlievert PM (1991) Cell and receptor requirements for streptococcal pyrogenic exotoxin T cell mitogenicity. Infect Immun 59: 1210–1214
Tomai MA, Aelion JA, Dockter ME, Majumdar G, Spinella DG, Kotb M (1991) T cell receptor V gene usage by human T cell stimulated with the superantigen streptococcal M protein. J Exp Med 174: 285–288
Tomai MA, Schlievert PM, Kotb M (1992) Distinct T cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pepM5 protein. Infect Immun 60: 701–705
Carlsson R, Dohlstein M, Baketoft A, Sjöquist J, Sjöggren HO (1984) Staphylococcal protein A does not induce production of Interferon-in human mononuclear blood cells. Cell Immunol 86: 136–145
Schrezenmeier H, Fleischer B (1987) Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J Immunol Methods 105: 133–137
Iandolo J (1989) Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu Rev Microbiol 43: 375–402
Redpath MB, Foster TJ, Bailey CJ (1991) The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS Microbiol Lett 65: 151–155
Bailey CJ, Redpath MB (1992) The esterolytic activity of epidermolytic toxins. Biochem J 284: 177–180
Kappler JW, Kotzin BL, Herron L, Gelfand E, Bigler RD, Boylston A, Carrel S, Posneit CD, Choi Y, Marrack P (1989) Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811–814
Choi Y, Kotzin BL, Herron L, Callahan J, Marrack P, Kappler JW (1989) Interaction of Staphylococcus aureus toxin superantigens with human T cells. Proc Natl Acad Sci USA 86: 8941–8945
Herrmann T, Acolla RS, MacDonald HR (1989) Different staphylococcal enterotoxins bind preferentially to distinct MHC class II isotypes. Eur J Immunol 19: 2171–2174
Beharka AA, Armstrong JW, Iandolo JJ, Chapes SK (1994) Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins. Infect Immun 62: 3907–3915
Fleischer B, Bailey CJ (1991) Recombinant epidermolytic (exfoliative) toxin a of Staphylococcus aureus is not a superantigen. Med Microbiol Immunol 180: 273–278
Fischetti VA (1989) Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2: 285–314
Schmidt KH, Wadström T (1990) A secreted receptor related to M1 protein of Streptococcus pyogenes binds to fibrinogen, IgG and albumin. Zentralbl Bakteriol 273: 216–228
Akesson P, Schmidt KH, Cooney J, Björck L (1994) M1 and protein H: IgGFc-and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 300: 877–886
Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA (1988) Anti-phagocytic activity of streptococcal M protein: selective binding of complement control factor H. Proc Natl Acad Sci USA 85: 1657–1661
Schmidt KH, Mann K, Cooney J, Köhler W (1993) Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin. FEMS Immunol Microbiol 7: 135–144
Tomai M, Kotb M, Majumdjar G, Beachey EH (1990) Super antigenicity of Streptococcal M protein. J Exp Med 172: 359–362
Wang B, Schlievert PM, Gaber AO, Kotb M (1993) Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J Immunol 151: 1419–1429
Watanabe Ohnishi R, Aelion J, Le Gros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M (1994) Characterization of unique human TCR V specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol 152: 2066–2073
Knöll H, Kühnemund O, Havlicek J (1979) Mitogenic and antigenic properties of group A streptococcal M protein preparations. Immunobiology 156: 537–548
Fleischer B, Schmidt KH, Gerlach D, Köhler W (1992) Separation of mitogenic activity from streptococcal M protein. Infect Immun 60: 1767–1770
Esaki Y, Fukui Y, Sudo T, Yamamoto K, Inamitsu T, Nishimura RD, Hirokawa K, Kimura A, Sasazuki R (1994) Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein. Infect Immun 62: 1228–1235
Robinson JH, Atherton MC, Goodacre JA, Pinkney M, Weightman H, Kehoe MA (1991) Mapping T cell epitopes in group A streptococcal type 5 M protein. Infect Immun 59: 4324–4331
Braun MA, Gerlach D, Hartwig UF, Ozegowski JH, Romagne F, Carrel S, Kohler W, Fleischer B (1993) Stimulation of human T cells by streptococcal “superantigen” erythrogenic toxins (scarlet fever toxins). J Immunol 150: 2457–2466
Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR (1993) A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with amino-terminal homology to staphylococcal enterotoxins B and C. J Clin Invest 92: 710–719
Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J (1994) Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 62: 3731–3738
Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M (1994) Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 62: 5227–5233
Abe J, Forrester J, Nakahara T, Lafferty JA, Kotzin BL, Leung DY (1991) Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol 146: 3747–3750
Gerlach D, Knöll H, Köhler W, Ozegowski JH, Hribalova V (1994) Isolation and characterization of erythrogenic toxins. V. Identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol 255: 221–233
Gerlach D, Reichhardt W, Fleischer B, Schmidt KH (1994) Separation of mitogenic and pyrogenic activity from so-called erythrogenic toxin type B (streptococcal proteinase). Zentralbl Bakteriol 280: 507–514
Bohach GA, Hauser AR, Schlievert PM (1988) Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherischia coli. Infect Immun 56: 1665–1671
Iwasaki M, Igarashi H, Hinuma Y, Yutsudo T (1993) Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett 331: 187–192
Gerlach D, Günther E, Köhler W, Vettermann S, Fleischer B, Schmidt KH (1995) Isolation and characterization of a mitogen characteristic of group A streptococci (Streptococcuspyogenes). Zentralbl Bakteriol 282: 67–82
Sato H, Itoh T, Rikiishi H, Kumagai K (1994) Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen. Microbiol Immunol 38: 139–147
Itoh T, Satoh H, Isono N, Rikiishi H, Kumagai K (1992) Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein. Infect Immun 60: 3128–3135
Gerlach D, Alouf H, Moravek L, Pavlik M, Kohler W (1992) The characterization of two new low molecular weight proteins (LMPs) from Streptococcus pyogenes. Int J Med Microbiol Virol Parasitol Infect Dis 277: 1–9
McMillan RA, Bloomster TA, Saeed AM, Henderson KL, Zinn NE, Abernathy R, Watson DW, Greenberg RN (1987) Characterization of a fourth streptococcal pyrogenic exotoxin (SPED). FEMS Microbiol Lett 44: 317–322
Galelli A, Truffa Bachi P (1993) Urtica dioica agglutinin. A superantigenic lectin from stinging nettle rhizome. J Immunol 151: 1821–1831
Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D (1991) Selective depletion in HIV infection of T cells that bear specific T cell receptor V sequences. Science 254: 860–862
Soudeyns H, Routy JP, Sekaly RP (1994) Comparative analysis of the T cell receptor V repertoire in various lymphoid tissues from HIV-infected patients: evidence for an HIV-associated superantigen. Leukemia 8 [Suppl 1]: S95-S97
Dadaglio G, Garcia S, Montagnier L, Gougeon ML (1994) Selective anergy of V 8+ T cells in human immunodeficiency virus-infected individuals. J Exp Med 179: 413–424
Boyer V, Smith LR, Ferre F, Pezzoli P, Trauger RJ, Jensen FC, Carlo DJ (1993) T cell receptor V repertoire in HIV-infection individuals: lack of evidence for selective V deletion. Clin Exp Immunol 92: 437–441
Weber GF, Cantor H (1993) HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy. Med Hypotheses 41: 247–250
Boldt Houle DM, Rinaldo CRJ, Ehrlich GD (1993) Random depletion of T cells that bear specific T cell receptor V sequences in AIDS patients. J Leukoc Biol 54: 486–491
Chen ZW, Kou ZC, Shen L, Reimann KA, Letvin NL (1993) Conserved T cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 151: 2177–2187
Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A (1993) T-cell antigen receptor V subsets are not preferentially deleted in AIDS. AIDS 7: 625–631
Piuvezam MR, Russo DM, Burns JMJ, Skeiky YA, Grabstein KH, Reed SG (1993) Characterization of responses of normal human T cells to Trypanosoma cruzi antigens. J Immunol 150: 916–924
Roessner K, Fikrig E, Russell JQ, Cooper SM, Flavell RA, Budd RC (1994) Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors. Eur J Immunol 24: 320–324
Boitel B, Ermontal M, Panina Bordignon P, Mariuzza RA, Lanzavecchia A, Acuto O (1992) Prefential Vβ gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/MHC recognition. J Exp Med 175: 765–778
Murphy M, Friend DS, Pike Nobile L, Epstein LB (1992) Tumor necrosis factor-and IFN-expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). J Immunol 149: 2506–2512
Hauser AR, Schlievert PM (1990) Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol 172: 4536–4541
Bowness P, Moss PA, Tranter H, Bell JI, McMichael AJ (1992) Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V6.9 and V22. J Exp Med 176: 893–896
Legaard PK, Le Grand RD, Misfeldt ML (1991) The superantigen Pseudomonas exotoxin A requires additional functions from accessory cells for T lymphocyte proliferation. Cell Immunol 135: 372–382
Stuart PM, Woodward JG (1992) Yersinia enterocolitica produces superantigenic activity. J Immunol 148: 225–233
Uchiyama T, Mioshi-Akiyama T, Kato H, Fujimaki W, Imanishi K, Yan XJ (1993) Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol 151: 4407–4413
Abe J, Takeda T, Watanabe Y, Nakao H, Kobayashi N, Leung DY, Kohsaka T (1993) Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol 151: 4183–4188
Ohmen JD, Barnes PF, Grisso CL, Bloom BR, Modlin RL (1994) Evidence for a superantigen in human tuberculosis. Immunity 1: 35–43
Denkers EY, Caspar P, Sher A (1994) Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V5-bearing CD8+ lymphocytes. J Exp Med 180: 985–994
Hugin AW, Vacchio MS, Morse HC (1991) A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science 252: 424–427
Donahue JP, Marrack P, Kappler JW (1993) A hVβ3.1-specific superantigen is expressed by the human cell line Raji (cited in [83])
Kotzin BL, Leung DY, Kappler JW, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99–166
Thomson BJ, Nicholas J (1991) Superantigen function (letter). Nature 351: 530
Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuillier F, Charron D, Lotteau V, Scott-Algara D (1992) Evidence for a viral superantigen in humans. Nature 358: 507–510
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fleischer, B., Gerlach, D., Fuhrmann, A. et al. Superantigens and pseudosuperantigens of gram-positive cocci. Med Microbiol Immunol 184, 1–8 (1995). https://doi.org/10.1007/BF00216783
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00216783